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tricuspid regurgitation (TR) as the result of right ven-
tricular pressure or volume overload.1-8 With respect to
surgical treatment of functional TR, surgeons have
advocated not repairing the valve,1 performing a vari-
ety of tricuspid annuloplasty procedures,2-9 or per-
forming valve replacement.9-12 Because of the differ-
ences in both cause and treatment, TR may decrease
gradually after correction of the primary cardiac
lesion.1 However, in some patients, significant TR
remains after annuloplasty.5-9 There may be differences
in the degree of TR after surgical repair on the basis of
the primary cardiac lesion responsible for the TR. This
L eft-sided valvular heart disease (VHD) and left-to-right cardiac shunt disease often cause functional
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LONG-TERM EVALUATION OF TREATMENT FOR FUNCTIONAL TRICUSPID REGURGITATION WITH
REGURGITANT VOLUME: CHARACTERISTIC DIFFERENCES BASED ON PRIMARY CARDIAC LESION
study presents the long-term effects of treatment for TR
and shows characteristic differences on the basis of the
primary cardiac lesion. 
Methods
Patients. From April 1985 to September 1995, 276 patients
underwent valve operation for acquired VHD, and 60 patients
underwent repair of a secundum atrial septal defect (ASD).
Among the patients with VHD, 85 patients who had organic
TR or who underwent isolated aortic valve operation or con-
comitant cardiac procedures such as coronary artery bypass
grafting were excluded from the study. Organic TR was
defined as prolapse of the cusps, rheumatic valvulitis, or
destruction of the valve apparatus because of infective endo-
carditis, diagnosed with preoperative echocardiography.
Seven patients who died of cardiac complications early after
the operation and 8 patients who had repeat operations
because of dysfunction of the left-side valve repairs were also
excluded from the study. Among the patients with ASD, 10
patients who had organic TR or who underwent concomitant
coronary artery bypass grafting, mitral valve operation, or
operation for anomalous pulmonary venous drainage were
also excluded from the study. Among the remaining patients,
96 patients (30 men and 66 women) with a mitral valve lesion
or mitral and aortic valve lesions and 32 patients (14 men and
18 women) with ASD associated with functional TR were
enrolled in the study. For the patients with VHD, the main
left-sided lesions were mitral stenosis in 56 patients and
mitral regurgitation in 24 patients. Sixteen patients had both
mitral and aortic valve lesions. Open mitral commissurotomy
was performed in 4 patients; mitral valve replacement was
performed in 76 patients, and combined mitral and aortic
valve replacement was performed in 16 patients. All ASDs
were closed with a patch. 
Evaluation of TR. Echocardiographic studies were per-
formed within 5 days before the operation when the patient
was hemodynamically stable. Two-dimensional and Doppler
echocardiography was performed with Toshiba SSH-65A and
SSH-140A equipment (Toshiba Corp, Tokyo, Japan) with a
2.5 MHz transducer. Each patient lay quietly for 15 minutes
in a supine position and underwent the procedure in the left
lateral decubitus position while breathing quietly. The TR jet
was observed in the following 3 cross-sectional views:
parasternal long-axis view of the right ventricular inflow
tract, apical 4-chamber view, and parasternal short-axis view
at the level of the aortic valve. 
Calculation of TR volume. First, TR was observed in the 2
right-angle cross-sectional views with 2-dimensional color
Doppler echocardiography. The width of the base of the TR
jet at a right angle (a,b) was measured at the tricuspid valve
position in each view. The cross-sectional area (S) of the base
of the TR jet was calculated as an elliptical shape (S = p /4 ·
ab), where the major and minor axes were a and b. Next, a
continuous-wave Doppler echocardiogram was recorded
from the center of the base of the TR jet (the most accelerat-
ed point of the functional TR occurring as the result of dila-
tion of the anulus). The TR volume of 1 unit area (Vu) at this
point was calculated by integrating the parabolic flow veloc-
ity signal of the echocardiogram during the ejection phase
(Vu = 2/3 · vt; v, peak velocity; t, duration of regurgitation).
The TR volume per beat (VTR) is equal to the sum of the vol-
ume of 1 unit area per cross-sectional area, which is assumed
to build up a conical shape. This is because the volume of 1
unit area decreases in accordance with distance from the cen-
ter of the TR jet. The VTR can be calculated by the following
formula: 1/3 · S · Vu = p/ 18 · abvt (Fig 1). Because all of the
patients underwent atrial fibrillation, each value for VTR was
obtained from an average of more than 5 heart beats. In 2-
dimensional color Doppler echocardiography, the Doppler
gain was set at the maximum level where no background
noise was seen. In the continuous-wave Doppler echocardio-
gram, the angle between the Doppler beam and the direction
of the TR jet was provided within 20 degrees. The echocar-
diogram was passed through a high-pass filter (1600 Hz) to
eliminate the influence of the movement of the intracardiac
structure and was recorded on a stripchart at a paper speed of
50 mm/s. 
The tricuspid annular diameter (TAD) was measured at
end-diastole from 3 cross-sectional views (parasternal long-
axis view of the right ventricular inflow tract, apical 4-cham-
ber view, and parasternal short-axis view at the level of the
aortic valve) obtained with 2-dimensional echocardiography
with a 3.75 MHz transducer. This value was defined as the
maximum length of the tricuspid anulus determined by the
longest distance between the bases of the opposing 2 leaflets
in these 3 views. 
Other parameters. All patients underwent preoperative
right heart catheterization studies, including cineangiography
at the same time as Doppler studies. The right ventricular vol-
ume was obtained from the biplane cineangiograms by the
area-length method13 on an average of 5 heart beats exclud-
ing premature contractions. 
The degree of heart failure was based on New York Heart
Association (NYHA) functional class, the degree of hepato-
megaly, and indocyanine green measurement. 
Treatment of TR. There was a significant correlation
between preoperative TAD and VTR in the VHD group (r =
0.87; P < .0001) and the ASD group (r = 0.88; P < .0001).
The slope of the correlation line (TAD: x-axis, VTR: y-axis)
was steeper for the VHD group (y = 1.41x – 46.0) than the
ASD group (y = 1.11x – 37.6; Fig 2). In the patients with
VHD with a TAD of 40 mm or more and the patients with
ASD with a TAD of 45 mm or more, hepatomegaly, disap-
pearance rate of indocyanine green (k value), right atrial
mean pressure (RAMP), right ventricular end-diastolic pres-
sure (RVEDP), and right ventricular end-diastolic volume
index (RVEDVI) had deteriorated to the point that surgical
repair for TR was necessary (Tables I and II). 
TR was prospectively treated as follows in this series. In
VHD, TR was ignored in 39 patients with a TAD of less than
40 mm. A Kay2 annuloplasty was performed in 33 patients
with a TAD of less than 45 mm; a modified De Vega annulo-
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plasty was performed in 12 patients with a TAD of ‡ 45 mm
to 49 mm. In 12 patients with a TAD of ‡ 50 mm, a modified
De Vega annuloplasty, annuloplasty using a Carpentier ring
(32 mm), or tricuspid valve replacement was performed in 4
patients each. In the latter group, the method of treatment was
not prospectively randomized. Tricuspid valve replacement
was performed when there was severe long-standing func-
tional TR associated with some degenerative changes at the
edge of the cusps not detected by preoperative echocardiog-
raphy. In these cases, annuloplasty procedures did not
achieve a sufficient reduction of TR in the intraoperative eval-
uation and were promptly abandoned for a valve replace-
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Fig 1. Calculation of TR volume per beat (VTR).
ment. Mechanical (St Jude Medical, Inc, St Paul, Minn) or
bioprosthetic valves (Carpentier-Edward pericardial valves;
Baxter Healthcare Corp, Edwards Division, Santa Ana, Calif)
were each used in 2 patients. In ASD, TR was ignored in 16
patients with a TAD of less than 45 mm. A Kay annuloplasty
was performed in 11 patients with a TAD of ‡ 45 mm to 49
mm. All 5 patients with a TAD of ‡ 50 mm were treated with
a modified De Vega annuloplasty. 
The disappearance of regurgitation was confirmed intraop-
eratively by the injection of saline solution into the right ven-
tricle after TR repair, and recently in combination with trans-
esophageal echocardiography. In a modified De Vega
annuloplasty, the anterior anulus was also repaired in addition
to obliteration of the posterior leaflet. For a Kay or a modi-
fied De Vega annuloplasty, the dilated anulus was reduced to
2.5 fingerbreadths in the patients with VHD and 3 finger-
breadths in the patients with ASD, where the volume reduc-
tion of the right ventricle was likely due to closure of the
ASD. 
Follow-up. Except for 1 late death in the group with VHD,
all patients have been followed up, with good repair of the
primary cardiac lesions. None of them have undergone repeat
operation. The follow-up period ranged from 6 to 130 months
(mean, 79 months; median, 84 months). A postoperative
catheterization study was performed 1 month after the opera-
tion at the same time as Doppler study in all patients. Echo-
cardiograms and physical examinations were obtained every
6 months after the operation, and the most recent values of
these data were used as the postoperative values. Good repair
of the primary cardiac lesions was confirmed by postopera-
tive Doppler study, which showed a functional mitral orifice
area of greater than 2.5 cm2 and a pressure gradient across the
aortic valve of below 30 mm Hg with no perivalvular regur-
gitation in patients with VHD, and no leakage of the patch
repair of the ASD. 
Statistical analysis. Statistical analysis was performed
with the Stat View 4.11 software package (Abacus Concepts,
Inc, Berkeley, Calif). Values are expressed as the mean ±
standard deviation. Statistical differences were evaluated
with unpaired or the paired Student t test.
Results
Comparisons of the methods evaluating TR with
the surgical procedure. With the conventional 4-grade
classification based on the distance reached by TR jet
in 2-dimensional Doppler echocardiography,14 it was
difficult to decide on the treatment of TR, that is, repair
or no repair, in patients with grade II and III disease. In
contrast, the evaluation according to the VTR provided
a clearer guideline for requirement of TR repair (VTR
‡ 10 cc) before the operation (Fig 3).
Long-term changes in TR after repair. In the
patients with VHD with a TAD of less than 40 mm and
the patients with ASD with a TAD of less than 45 mm,
the VTR decreased gradually without TR repair (VHD,
5.3 ± 2.3 cc decreased to 1.8 ± 2.0 cc; ASD, 4.5 ± 2.0 cc
decreased to 0.8 ± 1.2 cc). In the patients with VHD with
a TAD of ‡ 40 mm to 49 mm and the patients with ASD
with a TAD of ‡ 45 mm to 49 mm, all patients experi-
enced a decrease in the VTR to less than 5 cc immediate-
ly after repair with a Kay or a modified De Vega annulo-
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Fig 2. Correlation of regurgitant volume per beat (VTR) and TAD at end-diastole. There is a significant correla-
tion between preoperative TAD and VTR in the VHD group (r = 0.87) and the ASD group (r = 0.88). However,
the slope of the correlation line is steeper for the VHD group than for the ASD group.
plasty (VHD, 15.6 ± 3.2 cc decreased to 1.8 ± 1.9 cc;
ASD, 13.2 ± 2.6 cc decreased to 1.2 ± 1.9 cc) and no
recurrence of VTR late after the operation. In the patients
with VHD with a TAD of 50 mm or more, 8 patients
have had a significant decrease in the VTR to less than 5
cc immediately after the creation of a Carpentier ring or
tricuspid valve replacement (29.0 ± 6.5 cc decreased to
1.4 ± 1.8 cc) with no late recurrence of VTR. The remain-
ing 4 patients had an immediate remarkable regression
of TR after a modified De Vega annuloplasty (24.0 ± 4.5
cc decreased to 5.4 ± 2.0 cc) but had a recurrence of the
VTR to above 10 cc late after the operation. In contrast,
all 5 patients with ASD in this category showed a
remarkable decrease in the VTR to less than 5 cc after a
modified De Vega annuloplasty (24.8 ± 3.1 cc decreased
to 2.2 ± 1.8 cc) and have had no recurrence of VTR. 
Changes in degree of heart failure after operation.
In the patients in whom TR was not treated, NYHA
functional class has significantly improved in those
patients with VHD and those patients with ASD (2.7 ±
0.5  to 1.3 ± 0.5 and 1.9 ± 0.6 to 1.1 ± 0.3; P < .0001,
respectively). Hepatomegaly, RAMP, RVEDP, and
RVEDVI have not shown any deterioration in both
groups. 
In the patients with repair of the tricuspid valve,
hepatomegaly, RAMP, RVEDP, pulmonary arterial
mean pressure (PAMP), RVEDVI, and NYHA func-
tional class significantly improved in both groups. In
the patients with VHD with a TAD of 50 mm or more,
however, these parameters significantly improved but
still remained less good than in those patients with a
TAD of ‡ 40 mm to 49 mm (Table III). In addition, 4
patients who underwent a modified De Vega annulo-
plasty had a gradual increase in clinical manifestations;
1 of them died of right heart failure late after operation.
The other 8 patients who underwent annuloplasty with
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Table I. Preoperative profile of patients with VHD with a TAD of <40 mm and of ‡ 40 mm 
TAD < 40 mm TAD ‡ 40 mm Difference 
(n = 39) (n = 57) P value of mean 95% CI
Age (yr) 56.2 ± 8.6 54.4 ± 8.5 .32 –1.8 –5.3 to 1.8
Sex (M:F) 11:28 19:38
NYHA class 2.7 ± 0.5 3.1 ± 0.6 <.0001 0.4 0.18 to 0.659
Hepatomegaly (fb) 0.2 ± 0.6 2.5 ± 1.6 <.0001 2.3 1.8 to 2.8
Indocyanine green (k) 0.140 ± 0.040 0.100 ± 0.037 .0004 –0.040 –0.060 to –0.020
RAMP (mm Hg) 4.6 ± 2.6 10.1 ± 3.9 <.0001 5.5 4.1 to 6.9
RVEDP (mm Hg) 6.3 ± 2.7 10.3 ± 3.2 <.0001 4.0 2.8 to 5.3
RVSP (mm Hg) 40.2 ± 13.2 45.5 ± 14.1 .07 5.3 –0.45 to 11.1
PAMP (mm Hg) 26.7 ± 7.8 30.1 ± 9.6 .12 3.4 –0.2 to 7.0
RVEDVI (mL/m2) 111.3 ± 20.3 186.4 ± 30.5 <.0001 75.1 63.9 to 86.3
RVEF (%) 53.1 ± 4.8 50.2 ± 4.8 .06 –2.9 –4.9 to –0.9
Values are expressed as mean ± standard deviation. Statistical differences were evaluated with the unpaired Student t test. fb, Finger-breadth below the right costal
margin; k, K value of indocyanine green measurement.
Table II. Preoperative profile of patients with ASD with a TAD of <45 mm and of ‡ 45 mm 
TAD < 45 mm TAD ‡ 45 mm Difference 
(n = 16) (n = 16) P value of mean 95% CI
Age (yr) 49.5 ± 12.6 54.9 ± 9.2 .18 5.4 –2.6 to 13.3
Sex (M:F) 5:11 9:7
NYHA class 1.9 ± 0.6 3.0 ± 0.7 <.0001 1.1 0.59 to 1.54
Hepatomegaly (fb) 0.3 ± 0.6 2.2 ± 1.5 <.0001 1.9 1.0 to 2.7
Indocyanine green (k) 0.156 ± 0.007 0.086 ± 0.031 .0037 –0.07 –0.11 to –0.03
RAMP (mm Hg) 4.0 ± 1.9 8.6 ± 3.1 <.0001 4.6 2.8 to 6.5
RVEDP (mm Hg) 6.5 ± 2.7 10.8 ± 3.1 .0003 4.3 2.2 to 6.3
RVSP (mm Hg) 35.9 ± 9.8 56.3 ± 18.3 .0005 20.4 9.7 to 30.9
PAMP (mm Hg) 18.9 ± 3.7 32.6 ± 10.6 <.0001 13.7 7.7 to 19.7
RVEDVI (mL/m2) 174.4 ± 10.5 226.3 ± 19.1 .0001 51.9 40.7 to 63.0
RVEF (%) 54.3 ± 4.9 51.3 ± 3.2 .06 –3.0 –6.0 to –0.03
Values are expressed as the ± standard deviation. Statistical differences were evaluated with the unpaired Student t test. fb, Finger-breadth below the right costal
margin; k, K value of indocyanine green measurement. 
a Carpentier ring or valve replacement have shown no
deterioration of these parameters. In contrast, all 5
patients with ASD with a TAD of ‡ 50 mm showed sig-
nificant improvement of these values to the same extent
as did those patients with a TAD of ‡ 45 mm to 49 mm
even after a modified De Vega annuloplasty (Table IV). 
Retrospective analyses of preoperative parame-
ters in patients who underwent TR repair. In the ret-
rospective preoperative analyses, disappearance rate of
indocyanine green (k value), RAMP, RVEDP, right
ventricular systolic pressure (RVSP), and right ventric-
ular ejection fraction (RVEF) showed significant
decreased values in the patients with TAD of 50 mm or
more when compared with those patients with a TAD
of ‡ 40 mm to 49 mm in the VHD group. In contrast, no
significant differences were seen between the patients
with a TAD of ‡ 50 mm and a TAD of ‡ 45 mm to 49
mm in the ASD group (Tables V and VI). 
Discussion
TR has been evaluated qualitatively by both invasive
and noninvasive measurements, but these assessments
are sometimes unreliable because of their individual
shortcomings.14-16 Right ventriculography sometimes
causes artificial regurgitation by the catheter, and the
distance reached by TR jet in color Doppler echocar-
diography has the variant gradings from the thin and
long jet to the thick and short jet. Our quantitative
method is based on the fact that VTR is equal to the sum
of the regurgitant volume of 1 unit area at the base of
TR. The VTR was calculated as the product of the cross-
sectional area of the regurgitant jet and the regurgitant
volume of 1 unit area, which are obtained from
Doppler ultrasound measurements at the base of the TR
jet. Therefore, even if the TR jet radiates like a fountain
or impinges on the atrial wall, the VTR can be calculat-
ed by measurements made at its base. This is the great
advantage of this method. The problems are that VTR is
not necessarily reproducible depending on circum-
stances and a smaller VTR may be estimated than the
actual regurgitant volume, because of our assumption
of the sum of the regurgitant volume of 1 unit area per
cross-sectional area building up a conical shape.
However, interobserver differences were scarcely seen
when the Doppler study was performed in the patient
with hemodynamic stability.17 In addition, the evalua-
tion with VTR could potentially provide a clearer guide-
line for TR repair (VTR ‡ 10 cc) when compared with
the conventional 4-grade classifications,14 as shown in
Fig 3. 
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Table III. Postoperative right heart failure parameters for patients with VHD who underwent TR repair
TAD ‡ 40 mm - 49 mm TAD ‡ 50 mm Difference 
(n = 45) (n = 12) P value of mean 95% CI
NYHA class 1.3 ± 0.5 2.2 ± 0.9 <.0001 0.9 0.52 to 1.31
Hepatomegaly (fb) 0.4 ± 0.6 2.0 ± 1.2 <.0001 1.6 1.1 to 2.1
RAMP (mm Hg) 7.0 ± 1.8 9.4 ± 2.3 .00016 2.4 1.2 to 3.6
RVEDP (mm Hg) 6.6 ± 3.0 9.9 ± 1.9 .0028 3.3 1.2 to 5.4
PAMP (mm Hg) 22.8 ± 6.6 22.8 ± 3.5 .98 0 –4.6 to 4.5
RVEDVI (mL/m2) 118.5 ± 18.5 150.2 ± 25.3 .0036 31.7 4.5 to 58.9
RVEF (%) 52.7 ± 3.2 48.8 ± 1.5 .030 –3.9 –7.5 to –0.44
Values are expressed as the mean ± standard deviation. Statistical differences were evaluated with the unpaired Student t test. fb, Finger-breadth below the right
costal margin.
Table IV. Postoperative right heart failure parameters for patients with ASD who underwent TR repair
TAD ‡ 45 mm - 49 mm TAD ‡ 50 mm Difference 
(n = 11) (n = 5) P value of mean 95% CI
NYHA class 1.3 ± 0.5 1.5 ± 0.4 .41 0.2 –0.4 to 0.8
Hepatomegaly (fb) 0.2 ± 0.4 1.0 ± 0.7 .01 0.8 0.2 to 1.4
RAMP (mm Hg) 4.4 ± 1.8 5.2 ± 1.9 .56 0.8 –2.9 to 4.5
RVEDP (mm Hg) 5.4 ± 2.0 5.2 ± 1.9 .90 –0.2 –3.8 to 3.4
PAMP (mm Hg) 24.2 ± 6.0 26.0 ± 5.1 .74 1.8 –10.5 to 14.1
RVEDVI(mL/m2) 138.5 ± 14.0 145.7 ± 22.5 .46 7.2 –12.8 to 27.2
RVEF (%) 52.2 ± 2.9 49.3 ± 9.4 .40 –2.9 –9.9 to 4.1
Values are expressed as the mean ± standard deviation. Statistical differences were evaluated with the unpaired Student t test. fb, Finger-breadth below the right costal
margin.
Functional TR is first originated by right ventricular
pressure or volume overload, with VHD causing the
former and ASD causing the latter. This is supported by
the result that PAMP in the patients with insignificant
TR was significantly lower in patients with ASD than
in patients with VHD (Tables I and II). Furthermore,
development of TR causes volume overload on the
right ventricle by TR itself along with dilation of the
tricuspid anulus.18,19 In support of this finding, the pre-
sent study showed that the preoperative VTR was direct-
ly proportional to the TAD in the VHD and ASD
groups, respectively. In addition in ASD, a left-to-right
shunt flow augments such volume loading. This may
explain the steeper slope for the correlation line for the
relationship between TAD and VTR in VHD, when
compared with in ASD. That is, the TR volume was
smaller in quantity in ASD than VHD when the TAD
was equal. 
Regarding estimation of the TAD, the TAD proved to
be reproducible regardless of the size or geometry of the
right ventricle. The TAD was associated with evidence
of right heart failure, and the patients with VHD with a
TAD of ‡ 40 mm and the patients with ASD with a TAD
of ‡ 45 mm required TR repair. Most of them experi-
enced remarkable improvement in TR and hemodynam-
ic and clinical findings after a Kay or a modified De
Vega annuloplasty. In the patients with severely dilated
anulus, however, the long-term changes of TR differed
somewhat between those patients with VHD and ASD.
In fact, in the patients with VHD with a TAD of ‡ 50
mm, the right heart parameters still remained less good
when compared with those patients with a TAD of <50
mm. In addition, 4 patients who underwent a modified
De Vega annuloplasty experienced a gradual increase in
TR and clinical manifestations late after the operation.
In contrast, in the patients with ASD in this category,
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Table V. Preoperative profile of patients with VHD with a TAD of ‡ 40 mm to 49 mm and ‡ 50 mm
TAD ‡ 40 mm - 49 mm TAD ‡ 50 mm Difference 
(n = 45) (n = 12) P value of mean 95% CI
Age (yr) 54.5 ± 8.8 54.3 ± 7.3 .94 –0.2 –5.8 to 5.4
Sex (M:F) 15:30 4:8
NYHA class 3.0 ± 0.6 3.4 ± 0.5 .021 0.4 0.07 to 0.81
Hepatomegaly (fb) 2.1 ± 1.4 4.2 ± 0.9 <.0001 2.1 1.2 to 2.9
Indocyanine green (k) 0.112 ± 0.032 0.088 ± 0.040 .0043 –0.024 –0.050 to –0.002
RAMP (mm Hg) 8.5 ± 3.2 14.1 ± 3.7 <.0001 5.6 3.4 to 7.8
RVEDP (mm Hg) 9.7 ± 2.9 12.5 ± 3.5 .0065 2.8 0.8 to 4.7
RVSP (mm Hg) 47.9 ± 14.6 36.5 ± 8.0 .01 –11.4 –20.1 to –2.7
PAMP (mm Hg) 31.4 ± 10.9 24.5 ± 5.1 .03 –6.9 –12.7 to –1.1
RVEDVI (mL/m2) 177.1 ± 24.7 221.3 ± 25.0 <.0001 44.2 28.0 to 60.3
RVEF (%) 51.8 ± 3.8 44.2 ± 3.2 <.0001 –7.6 –10.0 to –5.3
Values are expressed as the mean ± standard deviation. Statistical differences were evaluated using unpaired Student’s t text. fb, Finger-breadth below the right costal
margin; k, K value of indocyanine green measurement.
Table VI. Preoperative profile of patients with ASD with a TAD of ‡ 45 mm to 49 mm and ‡ 50 mm 
TAD ‡ 45 mm - 49 mm TAD ‡ 50 mm Difference 
(n = 11) (n = 5) P value of mean 95% CI
Age (yr) 56.7 ± 9.5 50.8 ± 8.0 .25 –5.9 –16.4 to 4.6
Sex (M:F) 3:8 2:3
NYHA class 2.7 ± 0.6 3.6 ± 0.5 .021 0.9 0.16 to 1.59
Hepatomegaly (fb) 1.5 ± 0.9 3.8 ± 1.3 <.001 2.3 1.1 to 3.6
Indocyanine green (k) 0.086 ± 0.040 0.085 ± 0.010 .96 –0.001 –0.05 to 0.05
RAMP (mm Hg) 7.5 ± 3.0 9.4 ± 4.6 .08 1.9 –1.5 to 5.3
RVEDP (mm Hg) 9.8 ± 2.8 12.0 ± 4.2 .07 2.2 –0.6 to 5.0
RVSP (mm Hg) 54.1 ± 21.5 59.4 ± 9.4 .66 5.3 –17.2 to 27.8
PAMP (mm Hg) 33.1 ± 12.6 31.6 ± 4.7 .80 –1.5 –14.2 to 11.2
RVEDVI (mL/m2) 215.9 ± 10.9 249.0 ± 11.4 <.0001 33.1 20.3 to 45.9
RVEF (%) 52.2 ± 2.9 49.3 ± 3.1 .09 –2.9 –6.3 to 0.5
Values are expressed as the mean ± standard deviation. Statistical differences were evaluated using unpaired Student’s t test. fb, Finger-breadth below the right costal
margin; k, K value of indocyanine green measurement.
these right heart parameters significantly improved to
the same extent as in those patients with a TAD of <50
mm and have experienced no deterioration even after a
modified De Vega annuloplasty. This might indicate that
De Vega annuloplasty is sufficient for ASD, although a
more rigid annuloplasty method or valve replacement is
mandatory for VHD in this category.
The retrospective preoperative analyses revealed that
the patients with VHD with a TAD of ‡ 50 mm showed
lower RVSP and RVEF (Table V). However, previous
studies20,21 have demonstrated that more severe TR is
accompanied by higher RVSP. We believe that the for-
ward flow of the right ventricle decreases with progres-
sion of TR. As a result, such a severe TR in this catego-
ry would have a lower RVSP because of right ventricular
dysfunction, indicative of a lower RVEF, as was proved
in this study. In contrast, the patients with ASD with a
TAD of ‡ 50 mm did not show such a decrease in RVSP
and RVEF. This indicates that in ASD, right ventricular
function did not deteriorate to the same extent as in
VHD, even in this category. This would be the reason
that the postoperative change of TR differed between
those patients with VHD and ASD in this category. 
We thank Dr Yoshimasa Maniwa for statistical consultation.
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